These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15752925

  • 1. Potential cardiovascular benefits of insulin sensitizers.
    Kunhiraman BP, Jawa A, Fonseca VA.
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):117-35. PubMed ID: 15752925
    [Abstract] [Full Text] [Related]

  • 2. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
    Fonseca VA.
    Am J Med; 2007 Sep; 120(9 Suppl 2):S18-25. PubMed ID: 17826042
    [Abstract] [Full Text] [Related]

  • 3. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors.
    Edelman SV.
    Rev Cardiovasc Med; 2003 Sep; 4 Suppl 6():S29-37. PubMed ID: 14668701
    [Abstract] [Full Text] [Related]

  • 4. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B, Lund SS, Vaag A.
    Ugeskr Laeger; 2009 May 04; 171(19):1598-602. PubMed ID: 19419642
    [Abstract] [Full Text] [Related]

  • 5. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
    Mazzone T.
    Am J Med; 2007 Sep 04; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
    [Abstract] [Full Text] [Related]

  • 6. Insulin resistance and PPAR insulin sensitizers.
    Bhatia V, Viswanathan P.
    Curr Opin Investig Drugs; 2006 Oct 04; 7(10):891-7. PubMed ID: 17086933
    [Abstract] [Full Text] [Related]

  • 7. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G.
    J Diabetes Complications; 2005 Oct 04; 19(3):168-77. PubMed ID: 15866064
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
    Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino R, Kondos GT, Perez A, Chen Z, Mazzone T.
    Circulation; 2008 Apr 22; 117(16):2123-30. PubMed ID: 18413496
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy.
    Wyne KL.
    Diabetes Obes Metab; 2006 Jul 22; 8(4):365-80. PubMed ID: 16776743
    [Abstract] [Full Text] [Related]

  • 13. C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.
    Nesto R.
    Diabet Med; 2004 Aug 22; 21(8):810-7. PubMed ID: 15270782
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ, Yellon DM.
    Heart; 2008 Jun 22; 94(6):706-14. PubMed ID: 18480348
    [Abstract] [Full Text] [Related]

  • 18. [Glitazones critically evaluated].
    Schernthaner G.
    Dtsch Med Wochenschr; 2007 Dec 22; 132(49):2619. PubMed ID: 18050024
    [No Abstract] [Full Text] [Related]

  • 19. Effect of pioglitazone on the drivers of cardiovascular risk in type 2 diabetes.
    Donnelly R.
    Int J Clin Pract; 2007 Jul 22; 61(7):1160-9. PubMed ID: 17511791
    [Abstract] [Full Text] [Related]

  • 20. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
    Panunti B, Fonseca V.
    Vascul Pharmacol; 2006 Jul 22; 45(1):29-35. PubMed ID: 16777491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.